The South and Central America pulse oximeters market is expected to reach US$ 1,415.14 million by 2027 from US$ 709.26 million in 2019; it is estimated to grow at a CAGR of 8.9% from 2020 to 2027.
The market growth is primarily attributed to the rising prevalence of respiratory diseases, outbreak of COVID 19 pandemic, and increasing incidence of congenital heart disease. However, inaccuracies in pulse oximeter readings obstruct the market growth to a certain extent.
The pulse oximeter is a noninvasive device used for monitoring the oxygen saturation levels in blood. It is mostly used in intensive care units, operating units, and emergency care units; the device is also used at high altitudes to assess patients’ oxygenation levels to determine if there is a need of external oxygen supply. A large percentage of world population suffers from various types of respiratory diseases. The patients suffering from respiratory disorders commonly experience difficulty in breathing and oxygen shortage, and thus need oxygen monitoring. According to a research study published in the Journal of Fungi in April 2018, 2.3 million people in Argentina were diagnosed with Coronary obstructive pulmonary disease, with a prevalence of 14.5% among the population with age more than 40. The increasing number of COVID-19 cases worldwide is also boosting the demand for pulse oximeters. Moreover, different types pulse oximeter devices are being widely used for routine monitoring at home.
There has been a rise in the use of pulse oximeter devices at hospitals and homes during the COVID-19 pandemic. However, lockdowns and supply chain disruptions limited the sales and manufacturing of pulse oximeters over a short period. Nonetheless, the overall impact on the pandemic on the pulse oximeters market in the South and Central America is considered positive.
The South and Central America pulse oximeters market, by type, is segmented into fingertip pulse oximeters, handheld pulse oximeters, wrist-worn pulse oximeters, and pediatric pulse oximeters. The handheld pulse oximeters segment accounted for the largest share of the market in 2019; however, the market for the fingertip pulse oximeters segment is expected to grow at the highest CAGR in the market during the forecast period.
On the basis of end user, the South and Central America pulse oximeters market is segmented into hospitals, clinics, and others. The hospitals segment held the largest share of the market in 2019, whereas the others segment anticipated to register highest CAGR in the market during the forecast period.
A few of the primary and secondary sources associated with this report on the South and Central America pulse oximeters market are the National Institute of Health (NIH); National Health Service (NHS); and Centers for Disease Control and Prevention (CDC).